|
Name |
Naphthalene, 1,2,3,4-tetrahydro-2,5,8-trimethyl-
|
Molecular Formula | C13H18 | |
IUPAC Name* |
2,5,8-trimethyl-1,2,3,4-tetrahydronaphthalene
|
|
SMILES |
CC1CCC2=C(C=CC(=C2C1)C)C
|
|
InChI |
InChI=1S/C13H18/c1-9-4-7-12-10(2)5-6-11(3)13(12)8-9/h5-6,9H,4,7-8H2,1-3H3
|
|
InChIKey |
CMWCSSCXHBQEPX-UHFFFAOYSA-N
|
|
Synonyms |
Naphthalene, 1,2,3,4-tetrahydro-2,5,8-trimethyl-; 2,5,8-Trimethyl-1,2,3,4-tetrahydronaphthalene; 30316-17-7; 2,5,8-Trimethyltetralin; 1,2,3,4-Tetrahydro-2,5,8-trimethylnaphthalene; NSC80435; 2,8-Trimethyltetralin; DTXSID10873247; NSC 80435; NSC-80435; AKOS006294675; 1,3,4-Tetrahydro-2,5,8-trimethylnaphthalene; 2,8-Trimethyl-1,2,3,4-tetrahydronaphthalene; Naphthalene,2,3,4-tetrahydro-2,5,8-trimethyl-
|
|
CAS | 30316-17-7 | |
PubChem CID | 141557 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 174.28 | ALogp: | 4.3 |
HBD: | 0 | HBA: | 0 |
Rotatable Bonds: | 0 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 0.0 | Aromatic Rings: | 2 |
Heavy Atoms: | 13 | QED Weighted: | 0.553 |
Caco-2 Permeability: | -4.568 | MDCK Permeability: | 0.00002620 |
Pgp-inhibitor: | 0.162 | Pgp-substrate: | 0.003 |
Human Intestinal Absorption (HIA): | 0.003 | 20% Bioavailability (F20%): | 0.806 |
30% Bioavailability (F30%): | 0.942 |
Blood-Brain-Barrier Penetration (BBB): | 0.851 | Plasma Protein Binding (PPB): | 95.94% |
Volume Distribution (VD): | 2.173 | Fu: | 3.20% |
CYP1A2-inhibitor: | 0.869 | CYP1A2-substrate: | 0.902 |
CYP2C19-inhibitor: | 0.626 | CYP2C19-substrate: | 0.818 |
CYP2C9-inhibitor: | 0.376 | CYP2C9-substrate: | 0.878 |
CYP2D6-inhibitor: | 0.111 | CYP2D6-substrate: | 0.926 |
CYP3A4-inhibitor: | 0.174 | CYP3A4-substrate: | 0.276 |
Clearance (CL): | 9.758 | Half-life (T1/2): | 0.164 |
hERG Blockers: | 0.023 | Human Hepatotoxicity (H-HT): | 0.111 |
Drug-inuced Liver Injury (DILI): | 0.074 | AMES Toxicity: | 0.15 |
Rat Oral Acute Toxicity: | 0.017 | Maximum Recommended Daily Dose: | 0.128 |
Skin Sensitization: | 0.53 | Carcinogencity: | 0.547 |
Eye Corrosion: | 0.366 | Eye Irritation: | 0.967 |
Respiratory Toxicity: | 0.208 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC002097 | 0.646 | D0WO8W | 0.284 | ||||
ENC001046 | 0.457 | D09RHQ | 0.260 | ||||
ENC000342 | 0.378 | D0A0FL | 0.250 | ||||
ENC003840 | 0.358 | D09QUQ | 0.250 | ||||
ENC001305 | 0.351 | D0X0RI | 0.246 | ||||
ENC002309 | 0.345 | D06FPQ | 0.243 | ||||
ENC000180 | 0.333 | D01JMC | 0.237 | ||||
ENC001082 | 0.327 | D01PJR | 0.237 | ||||
ENC000518 | 0.308 | D09OQV | 0.220 | ||||
ENC000614 | 0.304 | D0U3DU | 0.219 |